Lev M. Kats

12.7k total citations · 2 hit papers
38 papers, 8.8k citations indexed

About

Lev M. Kats is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lev M. Kats has authored 38 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Hematology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lev M. Kats's work include Acute Myeloid Leukemia Research (13 papers), Malaria Research and Control (13 papers) and Mosquito-borne diseases and control (11 papers). Lev M. Kats is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Malaria Research and Control (13 papers) and Mosquito-borne diseases and control (11 papers). Lev M. Kats collaborates with scholars based in Australia, United States and Austria. Lev M. Kats's co-authors include Pier Paolo Pandolfi, Leonardo Salmena, Yvonne Tay, Laura Poliseno, Ugo Ala, Ross L. Coppel, Judy Lieberman, Dror Weiss, Paolo Provero and Florian A. Karreth and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lev M. Kats

37 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

2011 5.6k citations Leonardo Salmena, Laura Poliseno et al. Cell profile →
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs

2011 821 citations Yvonne Tay, Lev M. Kats et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lev M. Kats Australia	25	6.9k	6.2k	827	772	463	38	8.8k
Sven Diederichs Germany	47	12.4k 1.8×	11.1k 1.8×	1.9k 2.3×	784 1.0×	155 0.3×	112	15.6k
Benjamin Haley United States	35	5.3k 0.8×	2.0k 0.3×	635 0.8×	902 1.2×	121 0.3×	75	6.6k
Zusen Fan China	49	5.2k 0.8×	2.4k 0.4×	1.3k 1.6×	2.4k 3.2×	150 0.3×	109	8.1k
Dipanjan Chowdhury United States	49	7.3k 1.1×	2.6k 0.4×	2.5k 3.0×	1.7k 2.2×	170 0.4×	104	9.7k
Natasha J. Caplen United States	40	6.9k 1.0×	3.4k 0.6×	861 1.0×	590 0.8×	127 0.3×	99	8.6k
Dan R. Robinson United States	31	5.2k 0.8×	3.8k 0.6×	1.5k 1.9×	679 0.9×	63 0.1×	101	7.6k
Silvia Sabbioni Italy	36	6.7k 1.0×	5.9k 0.9×	1.2k 1.4×	354 0.5×	62 0.1×	78	8.4k
Anna Tsykin Australia	26	3.7k 0.5×	2.8k 0.5×	983 1.2×	731 0.9×	89 0.2×	35	5.8k
Eiichiro Sonoda Japan	44	7.3k 1.1×	2.1k 0.3×	2.2k 2.7×	1.4k 1.8×	196 0.4×	75	9.0k
Judith M. Boer Netherlands	36	2.7k 0.4×	713 0.1×	650 0.8×	658 0.9×	652 1.4×	94	4.7k

Countries citing papers authored by Lev M. Kats

Since Specialization

Citations

This map shows the geographic impact of Lev M. Kats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lev M. Kats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lev M. Kats more than expected).

Fields of papers citing papers by Lev M. Kats

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lev M. Kats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lev M. Kats. The network helps show where Lev M. Kats may publish in the future.

Co-authorship network of co-authors of Lev M. Kats

This figure shows the co-authorship network connecting the top 25 collaborators of Lev M. Kats. A scholar is included among the top collaborators of Lev M. Kats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lev M. Kats. Lev M. Kats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kats, Lev M., et al.. (2025). Epigenetic reprogramming in multiple myeloma—Challenges and opportunities. International Journal of Cancer. 158(2). 423–432.

Kats, Lev M., et al.. (2023). The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches. Biochemical Society Transactions. 51(4). 1675–1686. 6 indexed citations

So, Joan, Alexander C. Lewis, Lorey Smith, et al.. (2022). Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. EMBO Molecular Medicine. 14(7). e15203–e15203. 17 indexed citations

Bjelosevic, Stefan, Andrea Newbold, Jennifer R. Devlin, et al.. (2021). Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia. Cancer Discovery. 11(6). 1582–1599. 50 indexed citations

Giuffrida, Lauren, Kevin Sek, Melissa A. Henderson, et al.. (2020). IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors. Molecular Therapy. 28(11). 2379–2393. 74 indexed citations

Kelly, Madison J., Joan So, Gareth P. Gregory, et al.. (2019). Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis. Nature Communications. 10(1). 1347–1347. 44 indexed citations

Kim, Sangkyu, Deborah A. Knight, Lisa Jones, et al.. (2018). JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias. Genes & Development. 32(11-12). 849–864. 21 indexed citations

Beavis, Paul A., Melissa A. Henderson, Lauren Giuffrida, et al.. (2017). Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy. Journal of Clinical Investigation. 127(3). 929–941. 259 indexed citations

Kats, Lev M., Stephin J. Vervoort, Rachel M. Cole, et al.. (2017). A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML. Leukemia. 31(6). 1466–1470. 23 indexed citations

10.

Ghisi, Margherita, Lev M. Kats, Frédérick Masson, et al.. (2016). Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia. Cancer Cell. 30(1). 59–74. 26 indexed citations

11.

Baker, Adele, Gareth P. Gregory, Inge Verbrugge, et al.. (2015). The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia. Cancer Research. 76(5). 1158–1169. 83 indexed citations

12.

Kats, Lev M., Donna W. Buckingham, Lionel Blanc, et al.. (2015). Interactions between Plasmodium falciparum skeleton-binding protein 1 and the membrane skeleton of malaria-infected red blood cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(7). 1619–1628. 23 indexed citations

13.

Xie, Han, Jun‐ichi Hanai, Jian-Guo Ren, et al.. (2014). Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells. Cell Metabolism. 19(5). 795–809. 374 indexed citations

14.

Kats, Lev M., Markus Reschke, Riccardo Taulli, et al.. (2014). Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance. Cell stem cell. 14(3). 329–341. 146 indexed citations

15.

Song, Su Jung, Keisuke Ito, Ugo Ala, et al.. (2013). The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation. Cell stem cell. 13(1). 87–101. 257 indexed citations

16.

Salmena, Leonardo, Laura Poliseno, Yvonne Tay, Lev M. Kats, & Pier Paolo Pandolfi. (2011). A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?. Cell. 146(3). 353–358. 5565 indexed citations breakdown →

17.

Kats, Lev M., et al.. (2008). Characterisation of PfRON6, a Plasmodium falciparum rhoptry neck protein with a novel cysteine-rich domain. International Journal for Parasitology. 39(6). 683–692. 17 indexed citations

18.

Kats, Lev M., et al.. (2008). Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations. Vaccine. 26(26). 3261–3267. 3 indexed citations

19.

Ferguson, David, Lev M. Kats, Belinda J. Morahan, et al.. (2007). Plasmodium falciparum Pf34, a novel GPI-anchored rhoptry protein found in detergent-resistant microdomains. International Journal for Parasitology. 37(11). 1233–1241. 30 indexed citations

20.

Kats, Lev M., Brian M. Cooke, Ross L. Coppel, & Casilda G. Black. (2007). Protein Trafficking to Apical Organelles of Malaria Parasites – Building an Invasion Machine. Traffic. 9(2). 176–186. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact